| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $6.68 ▲ +1.86% | Yesterday | $6.51 ▼ -0.78% | Tomorrow's Harvard Bioscience Inc. Common Stock (HBIO) setup is anchored to $6.56 and targets $6.68 (+1.86%). The near-term read is upside; watch $6.76 / $6.36 because daily realized volatility is about 8.00%. |
Tomorrow's Harvard Bioscience Inc. Common Stock (HBIO) setup is anchored to $6.56 and targets $6.68 (+1.86%). The near-term read is upside; watch $6.76 / $6.36 because daily realized volatility is about 8.00%. | ||||
| Week | $6.94 ▲ +5.77% | Last Week | $6.40 ▼ -2.43% | The 7-day Harvard Bioscience Inc. Common Stock model moves from $6.40 to $6.94 (+5.77%). It gives upside momentum context for this stock, so breaks around $6.76 / $6.36 matter more than a single tick. |
The 7-day Harvard Bioscience Inc. Common Stock model moves from $6.40 to $6.94 (+5.77%). It gives upside momentum context for this stock, so breaks around $6.76 / $6.36 matter more than a single tick. | ||||
| Month | $7.37 ▲ +12.30% | Last Month | $6.22 ▼ -5.17% | The 1-month Harvard Bioscience Inc. Common Stock target is $7.37 (+12.30%), compared with the live reference near $6.56. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Harvard Bioscience Inc. Common Stock target is $7.37 (+12.30%), compared with the live reference near $6.56. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $8.01 ▲ +22.08% | Last Year | $5.95 ▼ -9.27% | The 1-year Harvard Bioscience Inc. Common Stock scenario points to $8.01 (+22.08%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Harvard Bioscience Inc. Common Stock scenario points to $8.01 (+22.08%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $9.51 ▲ +45.00% | 5 Years Ago | $5.32 ▼ -18.90% | The 5-year Harvard Bioscience Inc. Common Stock view is $9.51 (+45.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Harvard Bioscience Inc. Common Stock view is $9.51 (+45.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $6.56 | Mid |
| Daily Change | -6.15% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 71% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $6.56 | Daily Change | -6.15% |
| Market Cap | $29.34M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.